BONAPH1DE, A Prospective Observational Study of Patients With Primary Hyperoxaluria Type 1 (PH1)

Study of Lumasiran in Healthy Adults and Patients With Primary Hyperoxaluria Type 1

NCT02706886 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Long Term Treatment of End Stage Renal Disease Patients With Lanthanum Carbonate (Fosrenol)

NCT00567723 ·Status: COMPLETED

Retrospective and Prospective Follow-up of Patients With Primary Hyperoxaluria Type 1 Treated With Lumasiran in France.

NCT06225882 ·Status: RECRUITING

Study of MCI-196 in Chronic Kidney Disease Stage V Subjects on Dialysis With Hyperphosphatemia

NCT00772382 ·Status: COMPLETED ·Phase: PHASE3

Nedosiran in Pediatric Patients From Birth to 11 Years of Age With PH and Relatively Intact Renal Function

NCT05001269 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate Lumasiran in Adults With Recurrent Calcium Oxalate Kidney Stone Disease and Elevated Urinary Oxalate Levels

NCT05161936 ·Status: TERMINATED ·Phase: PHASE2

Lumasiran in Hyperoxalaemic Patients on Haemodialysis

NCT06225544 ·Status: RECRUITING ·Phase: PHASE2

Study to Evaluate Safety, Tolerability, PK and PD of DCR-PHXC in PH Type 3 Patients

NCT04555486 ·Status: COMPLETED ·Phase: PHASE1

Efficacy and Safety of Lanthanum in Controlling Serum Phosphate Levels in Subjects With End Stage Renal Disease Who Require Treatment for High Levels of Phosphate in Their Blood

NCT00150566 ·Status: COMPLETED ·Phase: PHASE3

Safety & Efficacy of DCR-PHXC in Patients With PH1 and ESRD

NCT04580420 ·Status: RECRUITING ·Phase: PHASE2

Efficacy and Safety of Lanthanum Carbonate and Sevelamer Hydrochloride in Patients Receiving Haemodialysis for End Stage Renal Disease

NCT00151918 ·Status: COMPLETED ·Phase: PHASE3

Phase I Study of Alpha-Melanocyte Stimulating Hormone in Patients With Acute Renal Failure

NCT00004496 ·Status: COMPLETED ·Phase: PHASE1

Treatment of Primary Hyperoxaluria Type 1 With Nedosiran

NCT05993416 ·Status: NO_LONGER_AVAILABLE

A Study of MCI-196 in Chronic Kidney Disease Stage V Subjects on Dialysis With Hyperphosphatemia

NCT00542815 ·Status: COMPLETED ·Phase: PHASE3

Pharmacodynamic Study of Two Lanthanum Carbonate Formulations in Healthy Adults

NCT00880750 ·Status: COMPLETED ·Phase: PHASE1

Low Phosphate Diets in Patients With Early Stages of Chronic Kidney Disease

NCT00438932 ·Status: COMPLETED ·Phase: NA

Fosrenol and Phosphorus Balance - Lanthanum Carbonate

NCT01581996 ·Status: COMPLETED ·Phase: NA

Long Term Extension Study in Patients With Primary Hyperoxaluria

NCT04042402 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

A Long-term Administration Study of OPC-41061 in Patients With Autosomal Dominant Polycystic Kidney Disease (ADPKD) [Extension of Study 156-04-001]

NCT00841568 ·Status: COMPLETED ·Phase: PHASE2

Effect of Reducing Phosphorus Absorption on Cardiac Biomarkers in Hemodialysis Patients

NCT01781156 ·Status: UNKNOWN

mHealth for Phosphorus Management in CKD.

NCT05389826 ·Status: UNKNOWN ·Phase: NA

A Study to Assess the Tolerability of Oxylanthanum Carbonate in Patients With Chronic Kidney Disease on Dialysis

NCT06218290 ·Status: COMPLETED ·Phase: PHASE2

Lanthanum Carbonate (Fosrenol®) to Reduce Oxalate Excretion in Patients With Secondary Hyperoxaluria and Nephrolithiasis

NCT03346369 ·Status: UNKNOWN ·Phase: PHASE3

A Long-term Administration Study of OPC-41061 in Patients With Autosomal Dominant Polycystic Kidney Disease (ADPKD) (2) [Extension of Study 156-05-002]

NCT01022424 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of Fosrenol in Treating Elevated Serum Phosphate Levels in Adults With End Stage Renal Disease

NCT00160121 ·Status: COMPLETED ·Phase: PHASE4